Seqens is a global leader in the pharmaceutical industry, with over 30 years' experience in the development and manufacturing of APIs, intermediates and polymers.

Our state-of-the-art R&D facilities in Europe and in the US and our network of 8 manufacturing sites (GMP and nonGMP) enable us to innovate, develop and industrialize the most demanding molecules, and implement the best available technologies.

Seqens supports its customers from early-stage development to commercial production, offering tailored solutions for complex molecules.
As a trusted partner to over 1,000 customers worldwide, Seqens is backed by a strong CMC project management team, offering the highest level of service and commitment.